Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Prepaid Assets: 2017-2025

Historic Prepaid Assets for Aclaris Therapeutics (ACRS) over the last 8 years, with Jun 2025 value amounting to $4.2 million.

  • Aclaris Therapeutics' Prepaid Assets fell 32.41% to $4.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.2 million, marking a year-over-year decrease of 32.41%. This contributed to the annual value of $12.0 million for FY2024, which is 27.37% up from last year.
  • Aclaris Therapeutics' Prepaid Assets amounted to $4.2 million in Q2 2025, which was up 30.25% from $3.2 million recorded in Q1 2025.
  • Over the past 5 years, Aclaris Therapeutics' Prepaid Assets peaked at $19.7 million during Q3 2023, and registered a low of $3.2 million during Q1 2025.
  • Moreover, its 3-year median value for Prepaid Assets was $8.1 million (2023), whereas its average is $9.1 million.
  • Per our database at Business Quant, Aclaris Therapeutics' Prepaid Assets surged by 401.74% in 2021 and then tumbled by 78.32% in 2024.
  • Aclaris Therapeutics' Prepaid Assets (Quarterly) stood at $13.0 million in 2021, then rose by 3.85% to $13.5 million in 2022, then declined by 29.96% to $9.5 million in 2023, then increased by 27.37% to $12.0 million in 2024, then tumbled by 32.41% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q2 2025, $3.2 million for Q1 2025, and $12.0 million during Q4 2024.